Correlation Between Dow Jones and BioCryst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dow Jones and BioCryst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dow Jones and BioCryst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dow Jones Industrial and BioCryst Pharmaceuticals, you can compare the effects of market volatilities on Dow Jones and BioCryst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dow Jones with a short position of BioCryst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dow Jones and BioCryst Pharmaceuticals.
Diversification Opportunities for Dow Jones and BioCryst Pharmaceuticals
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dow and BioCryst is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Dow Jones Industrial and BioCryst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCryst Pharmaceuticals and Dow Jones is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dow Jones Industrial are associated (or correlated) with BioCryst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCryst Pharmaceuticals has no effect on the direction of Dow Jones i.e., Dow Jones and BioCryst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dow Jones and BioCryst Pharmaceuticals
Assuming the 90 days trading horizon Dow Jones Industrial is expected to generate 0.22 times more return on investment than BioCryst Pharmaceuticals. However, Dow Jones Industrial is 4.54 times less risky than BioCryst Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. BioCryst Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 4,150,310 in Dow Jones Industrial on September 18, 2024 and sell it today you would earn a total of 221,438 from holding Dow Jones Industrial or generate 5.34% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dow Jones Industrial vs. BioCryst Pharmaceuticals
Performance |
Timeline |
Dow Jones and BioCryst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Dow Jones Industrial
Pair trading matchups for Dow Jones
BioCryst Pharmaceuticals
Pair trading matchups for BioCryst Pharmaceuticals
Pair Trading with Dow Jones and BioCryst Pharmaceuticals
The main advantage of trading using opposite Dow Jones and BioCryst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dow Jones position performs unexpectedly, BioCryst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCryst Pharmaceuticals will offset losses from the drop in BioCryst Pharmaceuticals' long position.Dow Jones vs. Commonwealth Bank of | Dow Jones vs. AmTrust Financial Services | Dow Jones vs. Forsys Metals Corp | Dow Jones vs. Juniata Valley Financial |
BioCryst Pharmaceuticals vs. TG Therapeutics | BioCryst Pharmaceuticals vs. Axsome Therapeutics | BioCryst Pharmaceuticals vs. Seres Therapeutics | BioCryst Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |